On December 5th, a graying man in the audience of a seminar about cloning stood up and announced that he was starting to organize a clinic to clone human beings. Richard Seed, a Chicago-based entrepreneur, was not a familiar face to the crowd of geneticists, fertility experts and bioethicists. But, following the news last year about Dolly the cloned lamb, his audacious plan couldn't simply be laughed off. And journalists seemed to be as nonplused as the scientists who first heard the claim.
The following day, reporter Marilynn Marchione from the Milwaukee Journal Sentinel reported Seed's grand claim in the first five paragraphs of her story about the seminar, then veered off onto other more mundane topics covered at the meeting. Five days later, the Washington Times (which, unlike the Post, is not read widely) reported Seed's claim, along with reaction from a bioethicist and a cloning foe on Capitol Hill. Whether these reports went unnoticed or were simply dismissed as too outlandish isn't clear. But the story was not to die quietly.
My colleague at National Public Radio, Joe Palca, caught wind of Richard Seed's claim and decided to investigate. After flying to Chicago to interview the 69-year-old entrepreneur and some of his colleagues, Palca decided Seed was credible enough that his plan deserved to be aired. On January 6th, NPR reported that Seed was trying to raise money and line up collaborators to offer cloning as an alternative to other treatments for infertility. The report was skeptical about Seed's ability -both technically and financially -to carry off such a scheme. Seed is trained as a physicist, not a physician (though he has pursued some fertility research with success). And, as he made clear in the interview, Seed doesn't mind going against the current ethics about pursuing such research. "God made man in His own image," Seed said. "God intended for man to become one with God. We are going to become one with God. We are going to have almost as much knowledge and almost as much power as God. Cloning and the reprogramming of DNA is the first serious step in becoming one with God."
As if through spontaneous generation, all the fears about cloning got a fresh jolt of life
That report thrust Richard Seed into newspapers and broadcasts around the world. Ted Koppel interviewed him on ABC-TV's Nightline program. Secretary of Health and Human Services Donna Shalala appeared on CBS' Face the Nation to vow that Seed would not clone human beings on US soil. President Clinton even used his weekly radio address the following Saturday to express his displeasure.
"As if through spontaneous generation, all the fears, all the questions about cloning -Is it moral? Is it safe? Is it even possible? -seemed to get a fresh jolt of life," reported the Chicago Tribune, in an article carrying six bylines.
An editorial in the Boston Globe warned, "Richard Seed and his cloning clinic demand society's full attention. He should be as riveting as a man with a bomb, requiring thoughtful strategy, cool heads, and no sudden movements."
Nobody dismissed the claim as biologically impossible. Indeed, reporters in the US didn't spend much time exploring the many technical difficulties Seed would face. Edwin Chen at the Los Angeles Times stated "many experts believe that human cloning is at least three years away in terms of technical know-how." Who those experts are and why they believe that to be the case was left unsaid. Many reports noted that Dolly was Ian Wilmut's 277th attempt to clone a sheepand some of the failed attempts were lambs with severe birth defects.
The Chicago Tribune, which dispatched a platoon of reporters to cover the story, focused mainly on Seed the man: a Harvard-trained physicist who spent his career dreaming up wild but not impossible ideas, and who recently had suffered personal financial troubles. The Tribune tracked down a doctor who matched the general description of one of Seed's unnamed collaborators. He said he'd talked to Seed but wasn't in fact interested in starting a clinic with him.
The British press, on the other hand, spent much more time reporting on the plausibility of cloning humans. The Guardian made it seem simple: "Just take a cell from a nose or somewhere, put it in a laboratory dish, starve it and persuade it to forget that it is a specialized nose cell…" But the Times dwelt on the difficulties of human cloning. Grahame Bulfield, head of the Roslin Institute where Dolly the lamb was cloned, explained one of the most daunting challenges. "You would probably need a thousand eggs, yet a super-ovulated woman can only produce five. You are therefore going to need a whole lot of super-ovulated women to do this and probably up to 50 surrogate mothers."
All in all, the general tone was one of alarm. The Lancet, however, urged a more open-minded view of cloning research. And the Observer complained that there are much more serious -and current -issues raised by genetics research, such as the threat of genetic discrimination. "But we are too busy worrying about about a bearded buffoon who says he will clone a human -but never will." Richard F. Harris is a science correspondent at National Public Radio and president of the National Association of Science Writers. E-mail: rharris@nasw.org
